Poster exhibition
Diagnostic methods and tools

Programme

• • Poster
  • P 082

  Neutralizing properties of porcine antibodies against the hepatitis E virus – establishment of a cell culture-based assay

  • Nele Gremmel (Hannover / DE)

   Diagnostic methods and tools
• • Poster
  • P 083

  False-positive HIV diagnosis post SARS-CoV-2 infection – a case report

  • Gwenllian Appeltrath (Essen / DE)

   Clinical virology, Diagnostic methods and tools
• • Poster
  • P 084

  ERVexpress for quantifying human endogenous retroviruses and multi-sample quality control

  • Wen Liang (Neuherberg / DE)

   Clinical virology, Diagnostic methods and tools
• • Poster
  • P 085

  Monkeypox-Virus (MPXV) outbreak in Berlin – implementation of molecular diagnostics

  • Dr. Martin Obermeier (Berlin / DE)

   Diagnostic methods and tools, Epidemiology and public health
• • Poster
  • P 086

  Highly sensitive detection of SARS CoV-2 structural proteins by surface plasmon resonance sensing

  • Professor Petia Genova-Kalou (Sofia / BG)

   Diagnostic methods and tools, SARS-CoV-2
• • Poster
  • P 087

  Evaluation of the performance of the Abbott Alinity m Resp-4-Plex assay

  • Dr. Martin Obermeier (Berlin / DE)

   Diagnostic methods and tools, SARS-CoV-2
• • Poster
  • P 088

  Challenges in RNA secondary structure predictionof complete viral genomes

  • Sandra Triebel (Jena / DE)

   Diagnostic methods and tools
• • Poster
  • P 089

  Tetraspanin anchors as versatile molecular tools for SARS CoV-2 antibody diagnostic

  • Daniel Ivanusic (Berlin / DE)

   Diagnostic methods and tools, SARS-CoV-2
• • Poster
  • P 090

  Hyper-EINS – a tool for automated identification of insertions in the hepatitis E virus hypervariable region

  • Maximilian Klaus Nocke (Bochum / DE)

   Diagnostic methods and tools, Viral replication strategies 1 (RNA viruses)
• • Poster
  • P 092

  INSTAND External Quality Assessment (EQA) schemes for SARS-CoV-2 antibody detection

  • Dr. Martin Kammel (Duesseldorf / DE)
  • Prof. Dr. Heinz Zeichhardt (Berlin / DE)

   Clinical virology, Diagnostic methods and tools
• • Poster
  • P 094

  Evaluation of an in-house competitive IgG avidity assay for timing of primary Parvovirus B19 infection in pregnancy

  • Prof. Dr. Martin Enders (Stuttgart / DE)

   Clinical virology, Diagnostic methods and tools
• • Poster
  • P 095

  QCMD 2022 Poxviruses External Quality Assessment (EQA) pilot study – data from two EQA challenges

  • Dr. Oliver Donoso Mantke (Berlin / DE)

   Diagnostic methods and tools
• • Poster
  • P 096

  Vaccinia and cowpox virus-based assays for the detection of antibodies against monkeypox virus

  • Dr. Marica Grossegesse (Berlin / DE)

   Diagnostic methods and tools, Innate immunity
• • Poster
  • P 097

  European Virus Archive – a valuable resource for virologists and support organization to help control diseases such as mpox and Covid-19

  • Dr. Rebecca Surtees (Berlin / DE)

   Diagnostic methods and tools, Emerging viruses and zoonosis
• • Poster
  • P 098

  Evaluation of an automated real-time transcription mediated amplification (TMA) assay for detection and quantification of cytomegalovirus DNA in different clinical specimens

  • Markus Schneider (Tuebingen / DE)

   Clinical virology, Diagnostic methods and tools
• • Poster
  • P 099

  Respiratory virus screening in a post-pandemic world – leveraging SARS-CoV-2 testing infrastructure for high-throughput detection of 16 common respiratory pathogens in the hospital setting

  • Dr. Dominik Nörz (Hamburg / DE)

   Clinical virology, Diagnostic methods and tools
• • Poster
  • P 100

  A (r)evolutionary perspective on RNA-protein interactions – co-alignments of viral RPIs

  • Sarah Krautwurst (Jena / DE)

   Diagnostic methods and tools, Viral replication strategies 1 (RNA viruses)
• • Poster
  • P 101

  Autochthonous and travel-associated West Nile virus and Toscana virus infections in Berlin, Germany 2018-2022

  • Julia Schneider (Berlin / DE)

   Clinical virology, Diagnostic methods and tools
• • Poster
  • P 102

  Omicron-BA.4 and -BA.5-specific evaluation of ten widely used SARS-CoV-2 rapid antigen tests underlines their highly heterogeneous test quality

  • Franziska Krenn (Munich / DE)

   Clinical virology, Diagnostic methods and tools